American Medical Systems, Inc. v. Laser Peripherals, LLC

665 F. Supp. 2d 1025, 2009 U.S. Dist. LEXIS 95387, 2009 WL 3297556
CourtDistrict Court, D. Minnesota
DecidedOctober 13, 2009
DocketCivil 08-4798 (JNE/FLN)
StatusPublished
Cited by3 cases

This text of 665 F. Supp. 2d 1025 (American Medical Systems, Inc. v. Laser Peripherals, LLC) is published on Counsel Stack Legal Research, covering District Court, D. Minnesota primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
American Medical Systems, Inc. v. Laser Peripherals, LLC, 665 F. Supp. 2d 1025, 2009 U.S. Dist. LEXIS 95387, 2009 WL 3297556 (mnd 2009).

Opinion

ORDER

JOAN N. ERICKSEN, District Judge.

American Medical Systems, Inc., and its subsidiary, Laserscope, (collectively, AMS) assert claims of patent infringement against Laser Peripherals, LLC (LP). LP counterclaims for declarations of non-infringement and invalidity. The case is before the Court to construe disputed claim terms pursuant to Markman v. Westview Instruments, Inc., 517 U.S. 370, 116 S.Ct. 1384, 134 L.Ed.2d 577 (1996).

*1027 I. BACKGROUND

AMS owns U.S. Patent No. 5,428,699 (filed July 2, 1993), entitled “Probe Having Optical Fiber for Laterally Directing Laser Beam.” Russell Pon is the sole named inventor on the '699 Patent. According to the '699 Patent, such a probe can be used to treat benign prostatic hyperplasia, which causes an enlarged prostate, by laterally directing laser energy out of the tip of a waveguide onto selected portions of the enlarged prostate to cause necrosis of the tissue. The necrotic tissue sloughs off as small particles which are passed away during urination. The claims of the '699 Patent are directed to apparatuses for communicating and laterally directing electromagnetic energy and probes for treating benign prostatic hyperplasia.

AMS contends that LP inflinges independent claims 1 and 25, as well as dependent claims 27-30, of the '699 Patent. Claim 1 recites:

An apparatus for communicating and laterally directing electromagnetic radiation, comprising:
a waveguide having a tip for communicating electromagnetic radiation in a propagation direction to the tip of the waveguide;
a transmitting surface on the tip of the waveguide;
a reflecting surface on the tip of the waveguide for internally reflecting electromagnetic radiation communicated by the waveguide in a direction lateral to the propagation direction toward a particular area on the transmitting surface; and
wherein the particular area and the reflecting surface are disposed so that greater than about 90% of electromagnetic radiation reflected by the reflecting surface is incident on the particular area at below a critical angle for transmission through the transmitting surface in the lateral direction.

Claim 25 recites:

A surgical probe for treating benign prostatic hyperplasia (BPH), said probe, comprising:
a waveguide having a tip with a glass cladding extending to a distal end of the tip, the waveguide for communicating electromagnetic radiation in a first propagation direction to the tip of the waveguide;
means for positioning the waveguide during surgery;
a transmitting surface on the tip of the waveguide;
a reflecting surface on the tip of the waveguide for internally reflecting electromagnetic radiation communicated in the first propagation direction by the waveguide in a second propagation direction toward the transmitting surface; and
wherein at least 90% of all electromagnetic radiation reflected by the reflecting surface is incident on the transmitting surface at below a critical angle for transmission through the transmitting surface.

The parties dispute the construction of several terms in the asserted claims. 1

*1028 II. DISCUSSION

The construction of patent claims “is a matter of law exclusively for the court.” Markman v. Westview Instruments, Inc., 52 F.3d 967, 970-71 (Fed.Cir.1995) (en banc), aff'd, 517 U.S. 370, 116 S.Ct. 1384, 134 L.Ed.2d 577 (1996). The claims define the invention to which the patentee is entitled the right to exclude. Phillips v. AWH Corp., 415 F.3d 1303, 1312 (Fed.Cir.2005). Words of a claim are generally given their ordinary and customary meaning, which is the meaning that the term would have to a person of ordinary skill in the pertinent art at the time of the invention (i.e., as of the effective filing date of the patent application). Id. at 1312-13. “[T]he person of ordinary skill in the art is deemed to read the claim term not only in the context of the particular claim in which the disputed term appears, but in the context of the entire patent, including the specification.” Id. at 1313. Because the meaning of a claim term as understood by persons of skill in the art is often not immediately apparent, a court should look to the sources available to the public that show what a person of skill in the art would have understood the claim language to mean. Id. at 1314. “Those sources include ‘the words of the claims themselves, the remainder of the specification, the prosecution history, and extrinsic evidence concerning relevant scientific principles, the meaning of technical terms, and the state of the art.’” Id. (quoting Innova/Pure Water, Inc. v. Safari Water Filtration Sys., Inc., 381 F.3d 1111, 1116 (Fed.Cir.2004)).

The claims provide substantial guidance as to the meaning of particular claim terms. Id. In some cases, the use of a term within the claim provides a firm basis for construing the term. Id. Other claims of the patent, both asserted and unasserted, can be valuable sources of enlightenment as to the meaning of a claim term. Id. In many cases, because claim terms are normally used consistently throughout the patent, the usage of a term in one claim can illuminate the meaning of the same term in other claims. Id. In addition, differences among claims can be a useful guide in understanding the meaning of particular claim terms. Id. For example, the presence of a dependent claim that adds a particular limitation gives rise to a presumption that the limitation is not present in the independent claim. Id. at 1314-15.

The claims do not stand alone, however, but must be read in light of the specification, of which they are a part. Id. at 1315. The specification is always highly relevant to claim construction and usually is dispositive because it is the single best guide to the meaning of a disputed term. Id.

In addition to the claims and specification, a court should consider the patent’s prosecution history, if it is in evidence. Id. at 1317. This is because the prosecution history can “inform the meaning of the claim language by demonstrating how the inventor understood the invention and whether the inventor limited the invention in the course of prosecution, making the claim scope narrower than it would otherwise be.” Id.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

American Medical Systems, Inc. v. Biolitec, Inc.
774 F. Supp. 2d 375 (D. Massachusetts, 2011)
American Medical Systems, Inc. v. Laser Peripherals, LLC
712 F. Supp. 2d 885 (D. Minnesota, 2010)

Cite This Page — Counsel Stack

Bluebook (online)
665 F. Supp. 2d 1025, 2009 U.S. Dist. LEXIS 95387, 2009 WL 3297556, Counsel Stack Legal Research, https://law.counselstack.com/opinion/american-medical-systems-inc-v-laser-peripherals-llc-mnd-2009.